(Q44610619)

English

Efficacy and safety of fluticasone propionate 44 μg/salmeterol 21 μg administeredin a hydrofluoroalkane metered-dose inhaleras an initial asthma maintenance treatment

scientific article published on September 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Efficacy and safety of fluticasone propionate 44 μg/salmeterol 21 μg administeredin a hydrofluoroalkane metered-dose inhaleras an initial asthma maintenance treatment (English)

1 reference

10.1016/S1081-1206(10)63528-4

https://api.crossref.org/works/10.1016/S1081-1206(10)63528-4

19 March 2024

1 reference

based on heuristic

inferred from title

fluticasone propionate

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S1081-1206(10)63528-4

https://api.crossref.org/works/10.1016/S1081-1206(10)63528-4

19 March 2024

author name string

Gary Gross

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Leslie Baitinger

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Catherine Scott

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Paul Dorinsky

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Harold S. Nelson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533658

19 March 2024

James D. Wolfe

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533658

19 March 2024

Leon S. Greos

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533658

19 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14533658

19 March 2024

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S1081120610635284?httpAccept=text/xml

1 reference

10.1016/S1081-1206(10)63528-4

https://api.crossref.org/works/10.1016/S1081-1206(10)63528-4

19 March 2024

https://api.elsevier.com/content/article/PII:S1081120610635284?httpAccept=text/plain

1 reference

10.1016/S1081-1206(10)63528-4

https://api.crossref.org/works/10.1016/S1081-1206(10)63528-4

19 March 2024

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

91

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

263-269

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963528-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963528-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963528-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963528-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963528-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963528-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963528-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963528-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963528-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963528-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963528-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963528-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963528-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)63528-4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44610619&oldid=2105729656"